Jim Bell, center, chief administrative officer for the UM Medical School, chats with Marvin Parnes, right, associate vice president for research and executive director of research administration, and John Ballew, director of UM Health System facilities planning. They were awaiting the start of Tuesday's forum on possible uses for the Pfizer research campus.
Jim Woolliscroft was Harlan Hatcher’s personal physician, and near the end of the former University of Michigan president’s life, Woolliscroft made house calls to check in on him. That gave them time to talk. And one of the things they talked about was UM’s purchase of the property that became North Campus.
Hatcher told Woolliscroft that when UM leaders decided to buy the 800 acres of farmland north of Ann Arbor, they didn’t know exactly how they’d use it – but they knew it would transform the university.
Woolliscroft, dean of the UM Medical School, told that anecdote Tuesday afternoon to the 100 or so people gathered at a forum on the future of the Pfizer research campus, which UM is in the process of acquiring. This purchase isn’t quite as bold as the one made in the early 1950s, Woolliscroft said, but its potential to transform in unimaginable ways is great: “That opportunity is phenomenal.”
The forum was one of three held this year for faculty to talk about how the university will use the former Pfizer facility. Tuesday’s hour-long session focused on process, with administrators outlining just how they’ll go about deciding what academic research or other activities are located at the site. [Full Story]